Thea van de Mortel teaches into the Griffith University Master of Infection Prevention and Control program. You’ve tested negative for COVID using a rapid antigen test (RAT), but are a close contact ...
With our free press under threat and federal funding for public media gone, your support matters more than ever. Help keep the LAist newsroom strong, become a monthly member or increase your support ...
The FDA, on Oct 12, expanded the eligibility of the granted emergency use authorization (EUA) to Omicron BA.4/BA.5-adapted bivalent vaccines developed by Pfizer PFE/BioNTech BNTX and Moderna MRNA. The ...
Neil Mabbott does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond their ...
NEW YORK & MAINZ, Germany--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that the U.S. Food and Drug Administration (FDA) granted Emergency Use Authorization ...
Investigators determined that the BA.2 subvariant is less severe than the previous Delta variant and less severe to an even greater extent than the original Omicron variant In an analysis of COVID-19 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback